Assessment of readiness to transition from antenatal HIV surveillance surveys to PMTCT programme data-based HIV surveillance in South Africa: The 2017 Antenatal Sentinel HIV Survey.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 11 09 2019
revised: 27 10 2019
accepted: 03 11 2019
pubmed: 13 11 2019
medline: 25 4 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

South Africa has used antenatal HIV surveys for HIV surveillance in pregnant women since 1990. We assessed South Africa's readiness to transition to programme data based antenatal HIV surveillance with respect to PMTCT uptake, accuracy of point-of-care rapid testing (RT) and selection bias with using programme data in the context of the 2017 antenatal HIV survey. Between 1 October and 15 November 2017, the national survey was conducted in 1,595 public antenatal facilities selected using stratified multistage cluster sampling method. Results of point-of-care RT were obtained from medical records. Blood samples were taken from eligible pregnant women and tested for HIV using immunoassays (IA) in the laboratory. Descriptive statistics were used to report on: PMTCT uptake; agreement between HIV point-of-care RT and laboratory-based HIV-1 IA; and selection bias associated with using programme data for surveillance. PMTCT HIV testing uptake was high (99.8%). The positive percent agreement (PPA) between RT and IA was lower than the World Health Organization (WHO) benchmark (97.6%) at 96.3% (95% confidence interval (CI): 95.9%-96.6%). The negative percent agreement was above the WHO benchmark (99.5%), at 99.7% (95% CI: 99.6%-99.7%) nationally. PPA markedly varied by province (92.9%-98.3%). Selection bias due to exclusion of participants with no RT results was within the recommended threshold at 0.3%. For the three components assessed, South Africa was close to meeting the WHO standard for transitioning to routine RT data for antenatal HIV surveillance. The wide variations in PPA across provinces should be addressed.

Identifiants

pubmed: 31712090
pii: S1201-9712(19)30444-8
doi: 10.1016/j.ijid.2019.11.005
pmc: PMC8767461
mid: NIHMS1066962
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-56

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

AIDS. 2016 Jul 31;30(12):1951-60
pubmed: 27124900
HIV Med. 2011 Jan;12(1):46-53
pubmed: 20553336
PLoS One. 2017 Aug 22;12(8):e0183044
pubmed: 28829801
S Afr Med J. 2008 Sep;98(9):707-9
pubmed: 19113051
BMC Infect Dis. 2016 Mar 05;16:113
pubmed: 26945861
BMC Infect Dis. 2017 Jul 5;17(1):469
pubmed: 28679418
Int J Infect Dis. 2016 Nov;52:62-67
pubmed: 27616035

Auteurs

Selamawit A Woldesenbet (SA)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: selamawitw@nicd.ac.za.

Tendesayi Kufa (T)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Peter Barron (P)

School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Kassahun Ayalew (K)

Strategic Information Unit, Centers for Disease Control and Prevention, Pretoria, South Africa.

Mireille Cheyip (M)

Strategic Information Unit, Centers for Disease Control and Prevention, Pretoria, South Africa.

Brian C Chirombo (BC)

HIV and Hepatitis Program, World Health Organization, Pretoria, South Africa.

Carl Lombard (C)

Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.

Samuel Manda (S)

Biostatistics Unit, South African Medical Research Council, Pretoria, South Africa.

Yogan Pillay (Y)

HIV & AIDS, TB and Maternal, Child and Women's Health (MCWH), National Department of Health, Pretoria, South Africa.

Adrian J Puren (AJ)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa; Virology Department, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH